These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4033452)

  • 21. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception.
    Edelman AB; Gallo MF; Jensen JT; Nichols MD; Schulz KF; Grimes DA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004695. PubMed ID: 16034942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.
    Marshall LM; Spiegelman D; Goldman MB; Manson JE; Colditz GA; Barbieri RL; Stampfer MJ; Hunter DJ
    Fertil Steril; 1998 Sep; 70(3):432-9. PubMed ID: 9757871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in insulin receptors during oral contraception.
    De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
    J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.
    den Tonkelaar I; Oddens BJ
    Contraception; 1999 Jun; 59(6):357-62. PubMed ID: 10518229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
    Martin CW; Brown AH; Baird DT
    Contraception; 1998 Aug; 58(2):99-103. PubMed ID: 9773264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproductive factors and breast cancer.
    Kelsey JL; Gammon MD; John EM
    Epidemiol Rev; 1993; 15(1):36-47. PubMed ID: 8405211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.
    Lauring JR; Lehman EB; Deimling TA; Legro RS; Chuang CH
    Am J Obstet Gynecol; 2016 Sep; 215(3):330.e1-7. PubMed ID: 27059507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
    Holman CD; Armstrong BK; Heenan PJ
    Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of method of contraception and cigarette smoking on menstrual patterns.
    Brown S; Vessey M; Stratton I
    Br J Obstet Gynaecol; 1988 Sep; 95(9):905-10. PubMed ID: 3191064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Post-pill amenorrhea "syndrome" (author's transl)].
    Tadjerouni A; Filci O; Caufriez A; Hermite ML; Robyn C
    Contracept Fertil Sex (Paris); 1983 May; 11(5):725-30. PubMed ID: 12338680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menarche, menstruation, sexual relations and contraception of adolescent females with Down syndrome.
    Goldstein H
    Eur J Obstet Gynecol Reprod Biol; 1988 Apr; 27(4):343-9. PubMed ID: 2968286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amenorrhea following oral contraception.
    Evrard JR; Buxton BH; Erickson D
    Am J Obstet Gynecol; 1976 Jan; 124(1):88-91. PubMed ID: 1244751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fertility awareness affects method use.
    Barnett B
    Netw Res Triangle Park N C; 1996; 17(1):9. PubMed ID: 12320448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contraceptive needs of midlife women.
    Jarrett ME; Lethbridge DJ
    Nurse Pract; 1990 Dec; 15(12):34-9. PubMed ID: 2284060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceptability of the combined oral contraceptive pill among Hong Kong women.
    Lo SS; Fan SY
    Hong Kong Med J; 2016 Jun; 22(3):231-6. PubMed ID: 27063439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menstrual cycle differences between women with type 1 diabetes and women without diabetes.
    Strotmeyer ES; Steenkiste AR; Foley TP; Berga SL; Dorman JS
    Diabetes Care; 2003 Apr; 26(4):1016-21. PubMed ID: 12663566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status.
    Larsson G; Milsom I; Lindstedt G; Rybo G
    Contraception; 1992 Oct; 46(4):327-34. PubMed ID: 1486771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal factors and the laboratory detection of Chlamydia trachomatis in women: implications for screening?
    Crowley T; Horner P; Hughes A; Berry J; Paul I; Caul O
    Int J STD AIDS; 1997 Jan; 8(1):25-31. PubMed ID: 9043977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.